Pioneers in Novel Product Development
Committed to providing innovative solutions for patients suffering from diabetic peripheral neuropathy
Our Mission and Values
Dynamis MedTech sees a reality where painful diabetic peripheral neuropathy doesn’t mean untreatable pain, and where people are empowered to claim their life back, one pain free day at a time.
Our mission is to give hope of leading a good quality of life and alleviate pain for millions of patients worldwide suffering with pDPN.
We put the patient at the heart of everything we do.
Our Investors
Our Story
Understanding
We’ve been working with world-leading medical consultants specialising in the management of pain caused by diabetes and have a deep understanding of pDPN and the role that electrical stimulation can play in alleviating pain for this debilitating condition.
Solutions
Having treated thousands of patients with pDPN, our medical advisors have seen first-hand the negative impact it has on quality of life. We understand that a new solution is clearly needed for the 70 million patients worldwide that don’t respond to existing medications and alternative treatments.
Hope
We exist to provide hope to this group of 70 million patients who are excluded from treatment.
Since founding Dynamis MedTech in 2021, Harry Khuman has assembled a world-class team of experts in diabetes, pDPN, neuroscience, electrical stimulation, electronics, engineering, design and development, manufacturing, innovation, industry, marketing and operations.
Empowerment
Together, our team possesses the necessary combination of skills and experience needed to research, develop and commercialise Sensetic, a novel electrical stimulation device for the management of pain.
In a world-first, Sensetic empowers you to manage pain from the comfort of your own home with it’s unique electrical impulses.
Investment Opportunities
We’re currently raising investment to develop and commercialise Sensetic.
To find out how you can be part of our journey, please contact us via the web form for details of our investment opportunity.
Help Us Break the Cycle of Pain
To learn more about investment opportunities, or Sensetic itself, please get in touch.
